Vir Biotechnology Inc. Common Stock vs Yum China Holdings Inc — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B), while Yum China Holdings Inc trades at $43.6 (market cap $14.58B). The key difference: Yum China Holdings Inc is far larger — about 8.3× Vir Biotechnology Inc. Common Stock's market cap, and Yum China Holdings Inc pays a 2.69% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Yum China Holdings Inc for 77 Days on average.
| VIR | YUMC | |
|---|---|---|
Market Cap | $1.76B | $14.58B |
Volume | 2,764,948 | 1,599,461 |
Sector | Health | Consumer Cyclical |
52-Week High | $11.78 | $57.95 |
52-Week Low | $5.12 | $39.98 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $1.32B | $15.49B |
Dividend Yield | — | 2.69% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YUMC trades at $43.11, up 0.63% today, with a bullish technical signal and strong analyst support (14 Buy, 5 Hold). The stock shows consistent earnings beats, with Q2 2026 EPS of $0.70 surpassing the $0.67 estimate. Revenue grew to $11.80B in 2025, and net income reached $929M. Recent corporate actions include a $0.29 dividend and the acquisition of Pizza Hut brand ownership in Mainland China, enhancing long-term growth prospects.
YUMC presents a favorable investment case with solid fundamentals, reasonable valuation (P/E 15.69), and positive earnings momentum. Key risks include competitive pressures in China's restaurant sector and macroeconomic sensitivity. Wall Street's average price target implies a 25.6% upside, supporting a bullish outlook for patient investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →